Bacterial Biofilms and Antibiotic Resistance: Molecular Mechanisms and Emerging Therapeutic Strategies

Bacterial biofilms are spatially organized microbial communities whose extracellular matrix and physiological heterogeneity complicate the treatment of persistent infections. This review examines molecular mechanisms underlying biofilm-associated antibiotic resistance and tolerance and evaluates emerging therapeutic strategies in relation to their experimental evidence and translational limitations. Biofilm recalcitrance results from interacting processes rather than a universal protective mechanism. Extracellular polymeric substances influence antimicrobial distribution and host interactions, while oxygen and nutrient gradients generate physiologically distinct populations with variable antibiotic susceptibility. Regulatory signaling, efflux systems, stress responses, persister cells, and the selection or exchange of resistance determinants further contribute to survival. Importantly, heritable antibiotic resistance must be distinguished from phenotypic tolerance and persistence, which can reduce bacterial killing without necessarily increasing minimum inhibitory concentrations. Emerging approaches include matrix-disrupting enzymes, quorum-sensing and antivirulence inhibitors, antimicrobial peptides, nanocarrier-based delivery, bacteriophages, persister-directed interventions, and mechanism-guided combination treatments. Although these strategies demonstrate promise in laboratory and selected preclinical models, their clinical utility remains constrained by species-specific effects, biofilm heterogeneity, safety considerations, and limited comparative human evidence. Progress will require standardized viability and regrowth endpoints, infection-relevant models, and rigorous evaluation alongside established antimicrobial treatment and source control. A mechanism-informed, infection-specific approach may improve the development and assessment of therapies for biofilm-associated infections.

Authors

Institutions

Publication Details

Journal
International Journal of Research and Innovation in Applied Science
Published
2026-11-16
DOI
https://doi.org/10.51584/ijrias.2026.11100093
Primary Topic
Bacterial biofilms and quorum sensing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bacterial Biofilms and Antibiotic Resistance: Molecular Mechanisms and Emerging Therapeutic Strategies

Ahmed Alamiery, Intisar Amer Hashim, Alyaa Mohammed Hasan Alghazi, Mohammed N. F. Albadri
1 links
International Journal of Research and Innovation in Applied Science
Bacterial biofilms and quorum sensing
article

Bacterial Biofilms and Antibiotic Resistance: Molecular Mechanisms and Emerging Therapeutic Strategies

Ahmed Alamiery, Intisar Amer Hashim, Alyaa Mohammed Hasan Alghazi, Mohammed N. F. Albadri
article en

Abstract

Bacterial biofilms are spatially organized microbial communities whose extracellular matrix and physiological heterogeneity complicate the treatment of persistent infections. This review examines molecular mechanisms underlying biofilm-associated antibiotic resistance and tolerance and evaluates emerging therapeutic strategies in relation to their experimental evidence and translational limitations. Biofilm recalcitrance results from interacting processes rather than a universal protective mechanism. Extracellular polymeric substances influence antimicrobial distribution and host interactions, while oxygen and nutrient gradients generate physiologically distinct populations with variable antibiotic susceptibility. Regulatory signaling, efflux systems, stress responses, persister cells, and the selection or exchange of resistance determinants further contribute to survival. Importantly, heritable antibiotic resistance must be distinguished from phenotypic tolerance and persistence, which can reduce bacterial killing without necessarily increasing minimum inhibitory concentrations. Emerging approaches include matrix-disrupting enzymes, quorum-sensing and antivirulence inhibitors, antimicrobial peptides, nanocarrier-based delivery, bacteriophages, persister-directed interventions, and mechanism-guided combination treatments. Although these strategies demonstrate promise in laboratory and selected preclinical models, their clinical utility remains constrained by species-specific effects, biofilm heterogeneity, safety considerations, and limited comparative human evidence. Progress will require standardized viability and regrowth endpoints, infection-relevant models, and rigorous evaluation alongside established antimicrobial treatment and source control. A mechanism-informed, infection-specific approach may improve the development and assessment of therapies for biofilm-associated infections.

International Journal of Research and Innovation in Applied ScienceVol. 11(10)
Al-Ayen Iraqi University (IQ)
Good health and well-being
Bacterial biofilms and quorum sensing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon